Use of 132 microglobulin to diagnose tubulo-interstitial renal lesions in children. Fractional excretion (FE) of 132 microglobulin (f32M) was studied in children with glomerular (N 114), tubular (N 50) or other (N = 18) renal diseases. FE-f32M (normal C 0.36%) was significantly (P cc 0.001) lower in glomerular diseases (mean 0.104%) than in tubular lesions (mean 4.27%). Unexpectedly, several patients with glomerular disease were found to have increased values for FE-f32M. To determine whether this was due to a tubular component in a primary glomerular disease process, FE-132M was measured in 30 children with various glomerulopathies who underwent renal biopsy. Thirteen of these patients had tubulo-interstitial lesions in addition to their glomerular disease. FE-/32M in these patients averaged 3.76% (range 0.14 to 44.6%); only two results were normal. Mean FE-thM in the 17 patients
without biopsy evidence of tubulo-interstitial disease was 0.063% (range 0.02 to 0.34%); all values were in the normal range. The types of glomerular diseases in the two groups of patients were similar. Patients with a glomerular lesion complicated by tubulo-interstitial lesions had a poorer prognosis than did those with a pure glomerular disease. The high incidence of tubulo-interstitial lesions in patients with glomerular diseases was unexpected. Our data demonstrates that FE-thM represents a reliable non-invasive method to diagnose such involvement. Measurements of f32M also provide a convenient method to follow the course and response to treatment of renal tubular injury. j32-mieroglobulin (Ø2M), a protein with a molecular wt of 11,800 daltons, is present on the cell surface of most nucleated cells [I] as the small subunit of HLA class I antigens [2] .
Measurable concentrations of the protein are present in most biologic fluids [3] . Levels in the serum reflect both the production and excretion rates of the protein. Under most conditions, production rates and serum concentrations of f32M are remarkably stable, although increased values may be seen with malignancies [4, 51, in infections [6] , and with certain immunologic disorders [7] . Since the kidney represents the major excretory pathway for the protein, alterations in serum Ø2M concentrations most often result from changes in the level of renal function. Indeed, it has been suggested that changes in the serum level of thM may be a better indicator of alteration in glomerular filtration rate (GFR) than equivalent levels of creatmine [8] .
The removel of 2M from the serum is primarly by glomerular filtration although some peritubular uptake of the protein may also occur [91. The glomerular sieving coefficient for /32M exceeds 0.8 [10] so that large quantities of the protein are filtered each day. More than 99.9% of the filtered protein is reabsorbed and catabolized by the proximal convoluted tubule.
Consequently, normal urine contains low concentnstions of f32M-typically less than 360 fkg/liter [11] , except in the neonate. The urinary levels of f32M peak by the fifth day of life and show a gradual decline until normal adult values are reached by three months of age [12] . No tubular maximum (Tm) for human f32M reabsorption has been found [9] so that the filtered load of 2M has little, if any, effect on the urinary loss of this protein.
Thus, most studies suggest that the urinary excretion of 132M is determined primarily by proximal tubular function. Tubular damage secondary to ischemia [131 and to a variety of toxins [14] and drugs [15] [16] [17] [18] [19] results in increased urinary levels of2M.
The present study was undertaken to assess the clinical usefulness of /32M determinations in diagnosing tubular involvement in a wide variety of renal diseases in children. We investigated whether this noninvasive test could be helpful in separating tubular from glomerular diseases and in following the course and treatment of patients with tubular diseases.
Methods
One hundred and eighty-two children whose ages ranged from one to nineteen years and who had a variety of renal diseases (Table 1) were studied. The diagnosis was established by renal biopsy in those patients where it could not be established from clinical and laboratory data. Patients receiving known nephrotoxic drugs such as aminoglycosides [17] , methieillin [18], methotrexate [19] , those exposed to heavy metals [14] , those receiving parental hyperalimentation [20] and those with active urinary tract infections [21, 22] or sepsis [231 were excluded from the study since the renal handling of p2M has been shown to be modified in these conditions. Patients receiving immunosuppressive agents were included in the study, These agents are not known to alter the tubular handling of f32M, although they can cause a reduction in serum levels by decreasing production [24] . Several of the patients were studied serially so that there were 241 observations on the 182 patients.
Concentrations of $2M in serum and urine were measured in 172 of these children at the time that GFR was measured by Portman et al inulin clearance using standard clearance methodology [251. In these studies, after the volume of voided urine had been measured, an aliquot of the urine was collected for /32M determination. The pH of all these samples was > 5.5, a level at which $2M degradation does not occur [261, and in 215 of the 226 samples, pH ranged between 6 and 7. Nevertheless, every sample was further alkalinized immediately with 0.1 N sodium hydroxide to a pH of> 6.5 to ensure no decomposition of f32M which occurs in acid urines [27] . The remaining 10 children all of whom had acute tubular necrosis, did not have inulin clearance measurements. In these children, FE-J32M was calculated from creatinine and f32M levels in urine and plasma obtained simultaneously.
Urine and serum were analyzed for p2M by a commercially available radioimmunoassay (Phadebus-50, Pharmacia, Uppsala, Sweden). Samples not analyzed on the day of collection were frozen at -70°C until analyzed. Preliminary studies showed that freezing did not affect j32M concentration, although repeated freezing and thawing did decrease these levels. Reproducibility in our laboratory for repeated /32M measurements on serum and urine samples was 4.8%. Fractional excretion (FE) of 2M was calculated from the standard formula [281 using the inulin concentrations measured in the same urine and serum samples. In the age range of patients studied, the normal serum values for f32M range from 1.1 to 2.4 (mean 1.6) mg/liter, the normal range for FE-JM from 0.01 to 0.36% [241 and the normal urine concentration of /32M is 360 .rg/liter or less [11, 28, 29] . In 44 of the children, urine and plasma samples were also analyzed for creatinine by a modified Jaffe method [301 to permit comparison of creatinine and inulin when calculating
Of the children studied, 30 who were thought to have a glomerulonephritis, underwent renal biopsy to determine the nature of their renal disease. The need for percutaneous renal biopsy was determined by clinical criteria. In no case was the biopsy performed to obtain data for the study. The biopsy specimens were processed by standard pathological techniques for evaluation by light, immunofluorescent and electron microscopy. The pathologist was asked to evaluate these specimens for evidence of tubulointerstitial disease without knowledge of the 7M results which had been measured on the day before the renal biopsy was performed.
Data was analyzed by standard statistical methodology [31] . Distribution of values for serum and urine /.32M were skewed.
These values were subjected to logarithmic transformation before analysis. Statistical significance was considered established with a P value of < 0.05. The study was approved by the Human Studies Committee of Washington University before any data was obtained.
Results

Serum ,62M concentration
Serum f32M correlated well with FGR ( Fig. I ). Patients were divided into those who had diseases which were primarily glomerular, those with tubular disorders and those with other renal diseases. Visual inspection of the data suggested there were no differences between results from these groups. This was confirmed when data from each group was analyzed separately. There were no significant differences between the lines of regression calculated by the method of least squares for the three groups of patients.
Fractional excretion of l32M
The values for FE-2M in each of the disease categories are summarized in Table 1 . One hundred and forty-three observations were made on 114 patients with glomerular diseases. The mean value for FE-p2M in this group was 0.104% (Table 1) which is well within the normal range. One hundred and twenty-four of the individual results were normal. Abnormal (elevated) values were most often seen in patients with either membranoproliferative or membranous glomerulonephritis. Increased values were observed occasionally in most other glomerulopathies. Results from patients with nephrotic syndrome varied depending on the underlying disease process.
Normal values occurred in all patients who had minimal change Of the 71 observations made on 50 patients with diseases associated with tubular damage, only 14 were in the normal range. The mean value for FE-/32M in this group of patients was 4.27% or almost 12 times the upper limit of normal. This value was signifcaritly (P <0.001) increased from that in patients with glomerular diseases. Markedly elevated levels were found in many of the patients with tubular lesions. For example, the fractional excretion of f32M averaged 10.5% in subjects with the Fanconi Syndrome, 11.8% in those with acute tubular necrosis, and more than 50% in those with cystinosis. Variable results were seen in patients with obstructive uropathy and chronic pyelonephritis. Some of these patients had very high values, others were in the normal range; none of these patients had clinical or laboratory evidence for active infection at the time of study to account for such a variation in results.
Most of the patients with other renal disorders had normal FE-7M values. For example, each of the patients with polycystic kidney disease had a normal result, although it should be emphasized that these studies were performed early in the course of the lesion when all the values for GFR were in the normal range. Whether comparable results occur in patients with longer standing lesions, was not evaluated, Thirty-six of the 182 patients were studied twice. Values for FE-p2M agreed with one another in 34 of these children. One of the two patients with discordant values had membranoproliferalive glomerulonephritis; the initial value was normal, the repeal study six months later was elevated. FE-/32M was increased and GFR decreased in one patient during the acute nephritic phase Uof Henoch-Schonlein purpura; both results were normal in the second study four months later. Two patients were studied three times; each value for FE-f32M was normal in both of these patients; FE-2M was consistently elevated in the two patients with Fanconi syndrome who were studied a total of 12 times. Three patients had four studies each. In two of these patients all values for FE-2M were in agreement; in the third, who had membranous glomerulonephritis, the initial value was normal but each of the three subsequent values was increased.
FE-/32M was related to GFR. Patients with reduced values for GFR tended to have the higher values for FE-132M. Since, as a group, patients with glomerular diseases had better preserved levels of GFR than did those with tubular lesions (88.3 26.7 and 54.4 30.0 mlIminIl.73 m2 respectively; P < 0.001), the data was re-analyzed to determine whether differences in GFR accounted for the different values for FE-/32M in patients with glomerular and those with tubular diseases. In patients with tubular disorders, there was a significant inverse correlation between GFR and FE-/32M (r = 0.83; P < 0.001). Patients with glornerular diseases did not show an equivalent correlation (r = 0.04; NS). In Figure 2 , values for FE-f32M are compared in patients with tubular and those with glomerular diseases at different levels of GFR. At any given GFR, patients with tubular disorders had higher values for FE-/32M than did those with glomerular disorders. The higher values for FE-f32M at lower levels of GFR in the patients with tubular disease are apparent in this figure.
Creatinine as a glomerular marker
All of the preceeding values, except those in patients with acute tubular necrosis where clearances were not obtained, were calculated using inulin as the glomerular marker. Fortyfour patients with varying diagnoses (25 patients with glomerular disease and 19 with tubular lesions) and a wide range of values for inulin clearance (21 to 119 ml/min/1.73 m2) had fractional excretions of f32M calculated from inulin and from creatinine concentrations determined on the same samples. There was excellent agreement between the results from the two methods with a correlation coefficient of 0.97 (P < 0.001).
Thus, the data obtained in the present study can be applied equally well in situations in which creatinine rather than inulin is used to measure renal function.
Urine f32M concentrations
Results of the study were analyzed further using urine p2M concentrations rather than FE-J32M. The correlation between FE-and urinary concentration of f32M was highly significant (r = 0.90; P < 0.001: Fig. 3 ). The correlation coefficient was higher for patients with tubular lesions (r = 0.94) than for those with glomerular diseases (r = 0.67). In each disease category the number of normal results using either FE-f32M or urinary f32M agreed well ( Table 1) accurate in 72 of 80 instances (90.0% accuracy) in predicting tubular damage based on the FE-/32M. Repeated determinations of urinary [32M levels in individual patients usually agreed, although consistency was slightly less good than that for FE-/32M. Discordant results were obtained in three of the 36 patients studied twice, and in one sample each from a patient studied three times and one studied four times.
Renal biopsy ond the FE-f32M
As indicated above, some patients with apparently pure glomerular disease had elevated values for FE-[32M (Table 1) The remaining 13 patients had an interstitial nephritis. In six, the lesion consisted of focal areas of mild or moderate degrees of lymphocytic infiltration often accompanied by mild insterstitial edema, More marked lesions, including focal areas of fibrosis, were present in another four patients, one of whom had plasma cells as well as lymphocytes in the infiltrate.
Tubular atrophy was seen in the remaining three patients. In one this was associated with extensive areas of chronic lymphocytic and plasma cell infiltration in the interstitium. In another, eosinophils as well as mononuclear cells were present in the infiltrate. The third had diffuse interstitial fibrosis with IgO, IgA, 1gM and C3 demonstrated in the interstitium by immunofluoreseent microscopy. This was one of two patients in whom immunoglobulins or complement were identified in the interstitium.
Three patients had had previous renal biopsies. In two, biopsies performed two and four years earlier respectively, showed no evidence of interstitial disease. In both, the biopsies performed at the time of the /32M study demonstrated severe chronic interstitial inflammation. The third patient showed an inflammatory interstitial infiltrate consisting primarily of neutrophils at the time he presented with immune complex glomerulonephritis. Five years later, when he appeared to have recovered clinically, scattered areas of lymphocytie infiltration were the only abnormalities in the interstitium on a repeat biopsy. Twelve years after disease onset, the patient had rapid deterioration in renal function, and a third biopsy revealed atrophic tubules accompanied by interstitial fibrosis and immune complex deposits as already described.
The presence or absence of tubulo-interstitial disease was not associated with a particular glomerular or systemic disease.
Thus, there were no tubulo-interstitial lesions in seven patients with systemic lupus erythematosus, three with MCNS, two with Henoch-Schoenlein Purpura, two with IgA nephropathy and one patient each with proliferative glomerulonephritis, membranous glomerulonephriti s, and mesangial glomerulonephritis. The group with tubulo-interstitial involvement comprised three patients with systemic lupus erythematosus, three with membranous glomerulonephritis, two with Henoch-Schoenlein Purpura, two with membranoproliferative glomerulonephritis and one each with proliferative glomerulonephritis, rapidly progressive glomerulonephritis, and focal sclerosing glomerulonephritis.
FE-/32M in the 13 patients with tubulo-interstitial disease averaged 3.76% (observed range 0.14 to 44.6%). Only two of the 13 results were in the normal range. The highest values for FE-f32M tended to occur in patients with the most severe pathologic changes but increased values occurred also in patients in whom interstitial but no tubular lesions were seen on the biopsy. Measurements of urinary /32M concentrations forecast the absence of tubulo-interstitial disease in 16 of 17 cases in which this lesion was not present, and predicted the presence of such disease in 10 of 13 cases. Thus the precision of urinary p2M levels was slightly less than that of FE-[32M.
The presence of tubulo-interstitial lesions was associated with a poor outcome. Eight of the 13 patients with this lesion progressed to end-stage renal disease (ESRD). Only one of the 17 patients without tubulo-interstitial lesions developed ESRD (P < 0.005). The length of follow-up for the two groups of patients was comparable when either time from study ( Table 2) or time from onset of disease (6.9 2.9 yrs vs. 7.1 3.2 yrs, respectively: NS) to the present was analyzed. The nine patients who developed ESRD have been followed for 57.6 15 .1 months since study compared to 48.2 23.8 months (NS) for those who did not develop ESRD. 
Discussion
Measurements of 132M have been used for a number of clinical purposes. Urinary concentrations of the protein can identify renal tubular injury from heavy metals [14] and acute tubular necrosis [13] . Even mild tubular dysfunction, for example that in neonates with meconium stained amniotic fluid, can be identified by measurement of 132M [32] . Other reported uses for the measurement of the protein include differentiation of upper from lower urinary tract infections [211 and assessment of renal tubular maturation in neonates [33] . Serum levels of /32M have been used to predict renal transplant rejection [34, 351 and to monitor diabetic nephropathy [361. Indeed, it has been suggested that changes in serum levels of p2M may be a better indicator of changes in GFR, especially in children, than serum creatinine since the rate of production of /32M is not body mass dependent as is creatinine. In one study of 250 patients with various renal diseases, GFR estimated from serum levels of /32M were almost as reliable as values calculated from the clearance of 99m TC-DTPA [37] . Other studies have not confirmed such a relationship [38] . We found a statistically significant correlation between levels of serum /32M and GFR (Fig.  1 the mean value for this group of patients was more than 40 times higher than the equivalent value in patients with glomerulopathies. At any given level of GFR, patients with tubular disorders had higher values for FE-/32M than did those with glomerular diseases (Fig. 2) although there was overlap in results from the two groups of patients. It was at the lowest levels of GFR where the separation was most complete. In agreement with previous studies [39] patients with glomerulonephritis and a markedly reduced GFR had normal values for FE-2M; those with tubular diseases had elevated FE-f32M results. The excellent diagnostic value of measurements of FE-2M in identifying the existence of a tubular lesion is illustrated by the findings in the 30 patients who were thought to have a glomerular disease and who underwent renal biopsy. Thirteen of these patients had tubulo-interstitial lesions of whom 11 had high values for FE-1M. None of the patients without tubulo-interstitial involvement had elevated FE-f32M levels. The high incidence of these tubulo-interstitial lesions in the biopsied patients probably resulted from the indications used to establish the need for the biopsy. The clinical and laboratory findings in these patients were atypical and necessitated the establishment of an exact histologic diagnosis. Tubular disease was not suspected prior to biopsy, except in one patient who had had a previous biopsy.
These observations indicate that measurements of FE-/32M help to differentiate tubular from glomerular disease and will identify tubular involvement in a primary glomerular disease. The elevated values for FE-/32M in tubular disorders are most likely due to tubular damage, which reduces the ability of the proximal tubule to reabsorb the filtered load of this protein. We were unable to correlate the urinary excretion of 132M in our patients with the calculated filtered load of the protein, even if the sieving coefficient for f32M in renal disease was assumed to be 1.0. Since serum J32M values from patients with glomerular, tubular and other renal diseases overlapped completely (Fig. I) , there is no evidence that the sieving coefficient for this protein varied in the different disease categories, Thus, there is no evidence to support the concept that the elevated levels of urinary /32M were due to a marked increase in filtered load of 2M which overwhelmed tubular reabsorption of this protein.
Other studies support this conclusion. For example, the maximum tubular reabsorptive capacity for /32M could not be exceeded either when serum f32M levels were markedly increased in patients with normal renal function [38] or by infusions of the protein [91.
Since 2M measurements appear to be such a good indicator of tubular injury, they could have additional clinical uses to those already discussed. We found that sequential measurements provided useful information about changes in the level of tubular function. For example, the initial FE-f32M values in patients with acute tubular necrosis averaged 33.0 13.1%; they fell progressively to 9.0 4.2% by 10 to 20 days into the disease course and eventually returned to normal in those patients who were followed long-term. Another example of the usefulness of repeated values was provided by a three year old boy who had inflammatory bowel disease and chronic diarrhea.
He developed a nephrotic syndrome. A renal biopsy demonstrated membranous glomerulonephritis and an immunologically mediated tubulo-interstitial disease which was associated with the Fanconi syndrome. His initial value for FE-/32M was 96.6%. This value fell rapidly and progressively to below 6% within one month of instituting treatment with steroids. Relapses of the tubular disease were subsequently predicted by increasing values for FE-J3M, which occurred before any changes in GFR, amino-aciduria, or metabolic acidosis were documented.
Measurements of FE-f32M could have additional diagnostic value. For example, all the children with nephrotic syndrome secondary to MCNS had normal FE-M results; those with other causes such as focal sclerosis, membranous glomerulonephritis or membranoproliferative glomerulonephritis frequently had elevated values. Children with polycystic kidney disease had normal values for FE-7M; those with renal dysplasia tended to have elevated levels, Perhaps most importantly, FE-f32M may help to determine prognosis for patients. We found that patients who had a glomerular disease complicated by tubular involvement had elevated values for FE-f32M and a poorer prognosis than did those in whom only the glomeruli were diseased ( Table 2 ). The correlation between tubulo-interstitial lesions and poor prognosis has been noted previously [401, our observations indicate that measurements of FE-/32M help to identify those patients at risk.
The current observations suggest that measurements of urinary /32M concentration represent an excellent screening test for detecting tubulo-interstitial disease. If these values are elevated, FE-J32M should be measured for a more precise indicator of the presence of renal tubular disease. It must be remembered, however, that all of the current studies were performed under standardized conditions of mild diuresis which was induced to increase the accuracy of simultaneous measurements of inulin clearance. In addition, urine samples were alkalinized immediately upon collection to minimize the decomposition of 132M which occurs in an acid urine [27] . Whether random samples obtained under a variety of non-standard conditions would be equally reliable as a diagnostic tool was not evaluated in this study. In summary, the present study demonstrates that measurement of 2M, especially FE-p2M, provides a reliable method to identify tubular injury in renal disease states and may provide a useful guide to help determine prognosis in patients with these lesions,
